Yaohui Wu

Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial

Huiwen Jiang, Chenggong Li, Ping Yin et al. · American Journal of Hematology · 2019 · 133 citations · Full text

Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy

Huiwen Jiang, Lin Liu, Tao Guo et al. · Annals of Hematology · 2019 · 121 citations · Full text

Translational Medicine, Cell Therapy, Autoimmune Disease +9

A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial

Chenggong Li, Heng Mei, Yu Hu et al. · Blood · 2019 · 83 citations

miR-125b regulates cell progression in chronic myeloid leukemia via targeting BAK1.

Quan Li, Yaohui Wu, Yongkang Zhang et al. · PubMed · 2016 · 26 citations

Hematological Malignancy, Tumor Biology, Chronic Myeloid Leukemia +14

BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts

Q Li, Yaohui Wu, Shanshan Fang et al. · Cancer Gene Therapy · 2015 · 15 citations · Full text

Hematological Malignancy, Bcr/abl Oncogene-induced Pi3k, Medicine +9